Association Between Polymorphisms of NRF2 and Breast Cancer Risk in Japanese Population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association Between Polymorphisms of NRF2 and Breast Cancer Risk in Japanese Population

Published:2024-03-31 Issue:2 Volume:55 Page:67-73
ISSN:0388-1601
Container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics

Author:

OKANO Yasuko¹,USUI Kengo²,HANAMI Takeshi²,TAGURI Masataka³,YAMASHITA Toshinari⁴,MIYAGI Yohei⁵⁶

Affiliation:

1. Department of Radiation Oncology, Yokohama City University Graduate School of Medicine, Japan

2. Genetic Diagnosis Technology Unit, RIKEN Center for Integrative Medical Sciences, Japan

3. Department of Data Science, Yokohama City University School of Data Science, Japan

4. Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Japan

5. Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Japan

6. Department of Pathology, Kanagawa Cancer Center, Japan

Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Link

https://www.jstage.jst.go.jp/article/jscpt/55/2/55_67/_pdf

Reference31 articles.

1. 1) Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2015; 65 (1): 5-29. doi: 10.3322/caac.21254.

2. 2) Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med. 2000; 342 (8）: 564-71. doi: 10.1056/NEJM200002243420807.

3. 3) Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med. 2001; 344 (4): 276-85. doi: 10.1056/NEJM200101253440407.

4. 4) Dodson A, Parry S, Ibrahim M, Bartlett JM, Pinder S, Dowsett M, et al. Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199,300 patients. J Pathol Clin Res. 2018; 4 (4): 262-73. doi: 10.1002/cjp2.112.

5. 5) Bonnefoi H, Litière S, Piccart M, MacGrogan G, Fumoleau P, Brain E, et al. Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase Ⅲ trial. Ann Oncol. 2014; 25 (6): 1128-36. doi: 10.1093/annonc/mdu118.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3